HEPATITIS B AND D VIRUSES
Non‐immune candidates should be vaccinated.
If treatment for HBV is initiated, monitoring on treatment should be in accordance with guidelines in the general population.(Low, Strong)
with subsequent management based on evolution of test results over the first year.
HEPATITIS C VIRUS
- with daclatasvir plus sofosbuvir plus ribavirin considered and alternative.
HCV positive Donors
HEPATITIS E VIRUS
April 1, 2019
Last Updated Month/Year
March 16, 2023
External Publication Status
Country of Publication
These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation review the diagnosis, prevention, and management of viral hepatitis in the pre‐ and post‐transplant period.
Target Patient Population
Female, Male, Adolescent, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Operating and recovery room, Outpatient
Nurse, nurse practitioner, physician, physician assistant
Diagnosis, Prevention, Management
D014180 - Transplantation, D019737 - Transplants, D000998 - Antiviral Agents, D006505 - Hepatitis, D006518 - Hepatitis Viruses
antiviral, infection, transplant, solid organ transplant, hepatitis
Te, H, Doucette, K. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transplant. 2019; 33:e13514.